MarketCapJahresabschlüsse von Unternehmen
| Name | Aktualisierungsdatum | Bericht Hinzugefügt | Berichtstyp | Börse | Land | |
|---|---|---|---|---|---|---|
 |
VistaGen Therapeutics
VTGN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market |  |
 |
Neoleukin Therapeutics
NLTX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market |  |
 |
AmeriServ Financial
ASRV
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Cara Therapeutics
CARA
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market, SPB | |
 |
Fennec Pharmaceuticals
FENC
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Equillium
EQ
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
PDS Biotechnology Corporation
PDSB
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
ShotSpotter
SSTI
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Avenue Therapeutics
ATXI
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Park City Group
PCYG
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Monopar Therapeutics
MNPR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Milestone Scientific
MLSS
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Astrotech Corporation
ASTC
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
AXT
AXTI
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Ondas Holdings
ONDS
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Fate Therapeutics
FATE
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market, SPB | |
 |
Evofem Biosciences
EVFM
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Second Sight Medical Products
EYES
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
WidePoint Corporation
WYY
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
IT Tech Packaging
ITP
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American |  |
 |
VolitionRx Limited
VNRX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American |  |
 |
Phio Pharmaceuticals Corp.
PHIO
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
The Walt Disney Company
DIS
|
13.11.2025 | 2025 | Geschäftsbericht | NYSE, SPB | |
 |
GeoVax Labs
GOVX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Protalix BioTherapeutics
PLX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American |  |
 |
Arbutus Biopharma Corporation
ABUS
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
AgeX Therapeutics
AGE
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
BioNano Genomics
BNGO
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market, SPB | |
|
Relmada Therapeutics
RLMD
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Wrap Technologies
WRAP
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Kodiak Sciences
KOD
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market, SPB | |
 |
BioNano Genomics WT EXP 082123
BNGOW
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Vaxart
VXRT
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market, SPB | |
|
CuriosityStream
CURIW
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
CuriosityStream
CURI
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Yunhong CTI Ltd.
CTIB
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Vor Biopharma
VOR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Spero Therapeutics
SPRO
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Trevi Therapeutics
TRVI
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Precigen
PGEN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Cytosorbents Corporation
CTSO
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Beazer Homes USA
BZH
|
13.11.2025 | 2025 | Geschäftsbericht | NYSE | |
 |
Lordstown Motors Corp.
RIDE
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Fossil Group
FOSL
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
China Recycling Energy Corporation
CREG
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Broadwind
BWEN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Datasea
DTSS
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Omeros Corporation
OMER
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
TransAct Technologies Incorporated
TACT
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Cellectar Biosciences
CLRB
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Venus Concept
VERO
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Ideal Power
IPWR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Applied Therapeutics
APLT
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market, SPB | |
 |
PaySign
PAYS
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Security National Financial Corporation
SNFCA
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Marker Therapeutics
MRKR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Rekor Systems
REKR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Synlogic
SYBX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Homology Medicines
FIXX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Virgin Galactic Holdings
SPCE
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE, SPB | |
 |
Digimarc Corporation
DMRC
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Celsion Corporation
CLSN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Flux Power Holdings
FLUX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
BioAtla
BCAB
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Clene
CLNN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Rhinebeck Bancorp
RBKB
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Landmark Bancorp
LARK
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Co-Diagnostics
CODX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Ra Medical Systems
RMED
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Anterix
ATEX
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Sintx Technologies
SINT
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Lyra Therapeutics
LYRA
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Airgain
AIRG
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Cyclerion Therapeutics
CYCN
|
12.11.2025 | 2024 | Geschäftsbericht | Nasdaq Global Select Market | |
 |
Aprea Therapeutics
APRE
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Espey Mfg. & Electronics Corp.
ESP
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Air T
AIRT
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Lixte Biotechnology Holdings
LIXT
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
IF Bancorp
IROQ
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Aziyo Biologics
AZYO
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Pluristem Therapeutics
PSTI
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
LightPath Technologies
LPTH
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Sesen Bio
SESN
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Trxade Group
MEDS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
eGain Corporation
EGAN
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Ovid Therapeutics
OVID
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Annovis Bio
ANVS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Dyadic International
DYAI
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
|
Ocuphire Pharma
OCUP
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Aethlon Medical
AEMD
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Jerash Holdings (US)
JRSH
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Lifeway Foods
LWAY
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Kingstone Companies
KINS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
AcelRx Pharmaceuticals
ACRX
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Leap Therapeutics
LPTX
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Cassava Sciences
SAVA
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market, SPB | |
 |
Camber Energy
CEI
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Hepion Pharmaceuticals
HEPA
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
U.S. Global Investors
GROW
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
XOMA Corporation
XOMA
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Graybug Vision
GRAY
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
IRIDEX Corporation
IRIX
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Rockwell Medical
RMTI
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
|
XBiotech
XBIT
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Fathom Holdings
FTHM
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Atara Biotherapeutics
ATRA
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Xenetic Biosciences
XBIO
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Westwater Resources
WWR
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Team
TISI
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Dolphin Entertainment
DLPN
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
GBS
GBS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Evolution Petroleum Corporation
EPM
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Intellicheck
IDN
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Natural Alternatives International
NAII
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Arcturus Therapeutics Holdings
ARCT
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market, SPB | |
 |
PMV Pharmaceuticals
PMVP
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
ARCA biopharma
ABIO
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
QuickLogic Corporation
QUIK
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Gulf Island Fabrication
GIFI
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
Frequency Therapeutics
FREQ
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Great Elm Group
GEG
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
TransDigm Group Incorporated
TDG
|
12.11.2025 | 2025 | Geschäftsbericht | NYSE, SPB | |
 |
Creative Realities
CREX
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Kezar Life Sciences
KZR
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Digital Ally
DGLY
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Pieris Pharmaceuticals
PIRS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market |  |
 |
Global Water Resources
GWRS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Mexco Energy Corporation
MXC
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Aqua Metals
AQMS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Adverum Biotechnologies
ADVM
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
|
Repro Med Systems
KRMD
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Atea Pharmaceuticals
AVIR
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Artelo Biosciences
ARTL
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Vista Gold Corp.
VGZ
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
New Concept Energy
GBR
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Prelude Therapeutics Incorporated
PRLD
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Rockwell Automation
ROK
|
12.11.2025 | 2025 | Geschäftsbericht | NYSE, SPB | |
 |
BioXcel Therapeutics
BTAI
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Crown Crafts
CRWS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Franklin Covey Co.
FC
|
12.11.2025 | 2025 | Geschäftsbericht | NYSE | |
 |
Sensus Healthcare
SRTS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Pixelworks
PXLW
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Stratus Properties
STRS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Bolt Biotherapeutics
BOLT
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
FAT Brands
FAT
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Stereotaxis
STXS
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Bally's Corporation
BALY
|
12.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
 |
DiaMedica Therapeutics
DMAC
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Cross Country Healthcare
CCRN
|
12.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
Seite anzeigen 7 von 30